Castle Biosciences, Inc. · NASDAQ:CSTL
Stokes Frank sold 24,908 Castle Biosciences, Inc. shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 18, 2026
On Aug 14, 2026, Stokes Frank (Chief Financial Officer) sold 24,908 Castle Biosciences, Inc. shares at US$29.77 for US$742K, leaving 35,177 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 24,908 shares
- Price
- US$29.77
- Value
- US$742K
- Holding after
- 35,177 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | Sale | 24,908 | US$29.77 | 35,177 | Direct |